Clinical Trial Update: ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating ctDNA-guided therapy with sunitinib and regorafenib for gastrointestinal stromal tumors, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• Stivarga (regorafenib)
• Sutent (sunitinib)

Snippet

Sponsor: University of Miami | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: RECRUITING